.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Daiichi Sankyo
Chubb
Cipla
Novartis
Farmers Insurance
Dow
Healthtrust
Medtronic

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204435

« Back to Dashboard
NDA 204435 describes NEOMYCIN SULFATE, which is a drug marketed by Teva, Lannett, X Gen Pharms, Lannett Holdings Inc, Bristol Myers Squibb, Breckenridge Pharm, Roxane, Lilly, Sandoz, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm, and is included in twenty NDAs. It is available from seven suppliers. Additional details are available on the NEOMYCIN SULFATE profile page.

The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

Summary for 204435

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 204435

Ingredient-typeAminoglycosides

Suppliers and Packaging for NDA: 204435

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN SULFATE
neomycin sulfate
TABLET;ORAL 204435 ANDA Lannett Company, Inc. 0527-1210 0527-1210-01 100 TABLET in 1 BOTTLE, PLASTIC (0527-1210-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jun 10, 2016TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Moodys
Medtronic
Colorcon
Boehringer Ingelheim
Fuji
Mallinckrodt
Teva
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot